SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Proceeds from Long-Term Debt Issued
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Proceeds from Long-Term Debt Issued of $600.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q/A filed 2024-09-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2024-09-04
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. proceeds from issuance of long-term debt for the quarter ending 2024-03-31 was $600.00K.
| Period end | Proceeds from Issuance of Long-term Debt 3 month |
|---|---|
| 2024-03-31 | $600.00K 10-Q/A · filed 2024-09-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |